Mandate

Vinge advises CapMan on acquisition of Cederroth International AB

May 21, 2008

Vinge is advising funds managed by CapMan in connection with the acquisition of Cederroth International AB. The Cederroth group is a leading manufacturer and distributor in the toiletries and household, woundcare and healthcare categories of the consumer goods market and the first aid category in business-to-business market. The transaction is subject to applicable competition law approvals and other customary closing conditions.

The Vinge team advising CapMan includes corporate partner Jan Byström and corporate associates Malin Helgesen, Mats Hävermark, Erik Plith, Anna-Sofia Nilsson Prevell, Caroline Strömbäck and Martin Folke. Partner Mikael Ståhl and associate Sara Axelsson are advising on the financing of the transaction. Partner Johan Karlsson and associates Peter Forsberg and Emma Nörler are providing competition law advice. Partner Per Eric Alvsing and associates Tina Hård, Anna Möller and Kristoffer Nordman are providing intellectual property advice. Partner Fredrik Dahl and associate Per Westman are providing employment and benefits advice. Associate Johan Cederblad provides environmental advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025